Tuesday, July 12, 2016

UPDATE 4-Sage's drug for postpartum depression succeeds in mid-stage study

* Shares soar as much as 48 pct in early trading

(Adds CEO, analyst comments; updates shares)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)